Resources Investment Advisors, Llc. X4 Pharmaceuticals, Inc Transaction History

Resources Investment Advisors, Llc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$0.58 - $1.47 $4,044 - $10,250	-6,973 Reduced 24.49%	21,500 $12,000
Q1 2024 May 10, 2024	BUY	$0.72 - $1.46 $1,923 - $3,901	2,672 Added 10.36%	28,473 $39,000
Q4 2023 Feb 13, 2024	SELL	$0.61 - $0.99 $2,753 - $4,468	-4,514 Reduced 14.89%	25,801 $21,000
Q3 2023 Nov 14, 2023	BUY	$1.03 - $2.02 $5,319 - $10,433	5,165 Added 20.54%	30,315 $33,000
Q2 2023 Aug 07, 2023	BUY	$0.82 - $2.49 $20,623 - $62,623	25,150 New	25,150 $48,000

103

99.9M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $54.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.